.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
AstraZeneca
Fuji
Daiichi Sankyo
Queensland Health
US Department of Justice
Farmers Insurance
McKesson
Express Scripts
Merck

Generated: September 26, 2017

DrugPatentWatch Database Preview

ERYC 125 Drug Profile

« Back to Dashboard

Which patents cover Eryc 125, and what generic Eryc 125 alternatives are available?

Eryc 125 is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in ERYC 125 is erythromycin. There are ninety-eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

Summary for Tradename: ERYC 125

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list42
Clinical Trials: see list739
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYC 125 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
ERYC 125
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL062648-001Oct 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Teva
Cipla
Julphar
Boehringer Ingelheim
Colorcon
US Department of Justice
Chinese Patent Office
Argus Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot